A Live-Attenuated HSV-2 ICP0− Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine
Table 1
Survival rates in HSV-2 MS challenge experiments.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Survival rates in HSV-2 MS challenge experiments.